ClinicalTrials.gov
public full text
Public Domain
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions
An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc. (A subsidiary of Ranbaxy, Inc) with Zyrtec® Cetirizine Hydrochloride, 10 mg tablet of Pfizer Labs (Division of Pfizer Inc.) in healthy, adult, human subjects under fed condition
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions#803093
- Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition#1126025
- Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition#981688
- Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions#849698
- Bioequivalence Test of Hemay005 Tablets#838778
Record · ID 1161871
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive